Copyright Reports & Markets. All rights reserved.

Global Micafungin Sodium for Injection Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Micafungin Sodium for Injection Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Micafungin Sodium for Injection Consumption 2014-2024
        • 2.1.2 Micafungin Sodium for Injection Consumption CAGR by Region
      • 2.2 Micafungin Sodium for Injection Segment by Type
        • 2.2.1 50 mg Single-use Vial
        • 2.2.2 100 mg Single-use Vial
      • 2.3 Micafungin Sodium for Injection Consumption by Type
        • 2.3.1 Global Micafungin Sodium for Injection Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Micafungin Sodium for Injection Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Micafungin Sodium for Injection Sale Price by Type (2014-2019)
      • 2.4 Micafungin Sodium for Injection Segment by Application
        • 2.4.1 Candidemia
        • 2.4.2 Respiratory Mycosis
        • 2.4.3 Gastrointestinal Mycosis
      • 2.5 Micafungin Sodium for Injection Consumption by Application
        • 2.5.1 Global Micafungin Sodium for Injection Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Micafungin Sodium for Injection Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Micafungin Sodium for Injection Sale Price by Application (2014-2019)

      3 Global Micafungin Sodium for Injection by Players

      • 3.1 Global Micafungin Sodium for Injection Sales Market Share by Players
        • 3.1.1 Global Micafungin Sodium for Injection Sales by Players (2017-2019)
        • 3.1.2 Global Micafungin Sodium for Injection Sales Market Share by Players (2017-2019)
      • 3.2 Global Micafungin Sodium for Injection Revenue Market Share by Players
        • 3.2.1 Global Micafungin Sodium for Injection Revenue by Players (2017-2019)
        • 3.2.2 Global Micafungin Sodium for Injection Revenue Market Share by Players (2017-2019)
      • 3.3 Global Micafungin Sodium for Injection Sale Price by Players
      • 3.4 Global Micafungin Sodium for Injection Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Micafungin Sodium for Injection Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Micafungin Sodium for Injection Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Micafungin Sodium for Injection by Regions

      • 4.1 Micafungin Sodium for Injection by Regions
        • 4.1.1 Global Micafungin Sodium for Injection Consumption by Regions
        • 4.1.2 Global Micafungin Sodium for Injection Value by Regions
      • 4.2 Americas Micafungin Sodium for Injection Consumption Growth
      • 4.3 APAC Micafungin Sodium for Injection Consumption Growth
      • 4.4 Europe Micafungin Sodium for Injection Consumption Growth
      • 4.5 Middle East & Africa Micafungin Sodium for Injection Consumption Growth

      5 Americas

      • 5.1 Americas Micafungin Sodium for Injection Consumption by Countries
        • 5.1.1 Americas Micafungin Sodium for Injection Consumption by Countries (2014-2019)
        • 5.1.2 Americas Micafungin Sodium for Injection Value by Countries (2014-2019)
      • 5.2 Americas Micafungin Sodium for Injection Consumption by Type
      • 5.3 Americas Micafungin Sodium for Injection Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Micafungin Sodium for Injection Consumption by Countries
        • 6.1.1 APAC Micafungin Sodium for Injection Consumption by Countries (2014-2019)
        • 6.1.2 APAC Micafungin Sodium for Injection Value by Countries (2014-2019)
      • 6.2 APAC Micafungin Sodium for Injection Consumption by Type
      • 6.3 APAC Micafungin Sodium for Injection Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Micafungin Sodium for Injection by Countries
        • 7.1.1 Europe Micafungin Sodium for Injection Consumption by Countries (2014-2019)
        • 7.1.2 Europe Micafungin Sodium for Injection Value by Countries (2014-2019)
      • 7.2 Europe Micafungin Sodium for Injection Consumption by Type
      • 7.3 Europe Micafungin Sodium for Injection Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Micafungin Sodium for Injection by Countries
        • 8.1.1 Middle East & Africa Micafungin Sodium for Injection Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Micafungin Sodium for Injection Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Micafungin Sodium for Injection Consumption by Type
      • 8.3 Middle East & Africa Micafungin Sodium for Injection Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Micafungin Sodium for Injection Distributors
      • 10.3 Micafungin Sodium for Injection Customer

      11 Global Micafungin Sodium for Injection Market Forecast

      • 11.1 Global Micafungin Sodium for Injection Consumption Forecast (2019-2024)
      • 11.2 Global Micafungin Sodium for Injection Forecast by Regions
        • 11.2.1 Global Micafungin Sodium for Injection Forecast by Regions (2019-2024)
        • 11.2.2 Global Micafungin Sodium for Injection Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Micafungin Sodium for Injection Forecast by Type
      • 11.8 Global Micafungin Sodium for Injection Forecast by Application

      12 Key Players Analysis

      • 12.1 Astellas
        • 12.1.1 Company Details
        • 12.1.2 Micafungin Sodium for Injection Product Offered
        • 12.1.3 Astellas Micafungin Sodium for Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Astellas News

      ...

        13 Research Findings and Conclusion

        Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
        In 2013, Japan was the largest consumption place, with a consumption market share nearly 35.40%. In 2017, North America is the largest consumption place with the consumption market share of 28.98%.
        Astellas is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.

        According to this study, over the next five years the Micafungin Sodium for Injection market will register a -4.6% CAGR in terms of revenue, the global market size will reach US$ 290 million by 2024, from US$ 380 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Micafungin Sodium for Injection business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares, and growth opportunities of Micafungin Sodium for Injection market by product type, application, key manufacturers and key regions and countries.

        This study considers the Micafungin Sodium for Injection value and volume generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
        50 mg Single-use Vial
        100 mg Single-use Vial
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
        Candidemia
        Respiratory Mycosis
        Gastrointestinal Mycosis

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        Astellas
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Micafungin Sodium for Injection consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Micafungin Sodium for Injection market by identifying its various subsegments.
        Focuses on the key global Micafungin Sodium for Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Micafungin Sodium for Injection with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the consumption of Micafungin Sodium for Injection submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now